SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Robert K. Naviaux, Metabolic features of the cell danger response, Mitochondrion, 2014, 16, 7

    CrossRef

  2. 2
    Erik De Clercq, A Cutting-Edge View on the Current State of Antiviral Drug Development, Medicinal Research Reviews, 2013, 33, 6
  3. 3
    Erik De Clercq, Antivirals: Past, present and future, Biochemical Pharmacology, 2013, 85, 6, 727

    CrossRef

  4. 4
    Erik De Clercq, Highlights in Antiviral Drug Research: Antivirals at the Horizon, Medicinal Research Reviews, 2013, 33, 6
  5. 5
    Peng Zhan, Xuwang Chen, Dongyue Li, Zengjun Fang, Erik Clercq, Xinyong Liu, HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design, Medicinal Research Reviews, 2013, 33, S1
  6. 6
    Lachlan M. Blair, Jonathan Sperry, Natural Products Containing a Nitrogen–Nitrogen Bond, Journal of Natural Products, 2013, 76, 4, 794

    CrossRef

  7. 7
    Erik De Clercq, The Acyclic Nucleoside Phosphonates (ANPs): Antonín Holý's Legacy, Medicinal Research Reviews, 2013, 33, 6
  8. 8
    Suki Man-Yan Lee, Hui-Ling Yen, Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection, Antiviral Research, 2012, 96, 3, 391

    CrossRef

  9. 9
    Erik De Clercq, Ten Paths to the Discovery of Antivirally Active Nucleoside and Nucleotide Analogues, Nucleosides, Nucleotides and Nucleic Acids, 2012, 31, 4, 339

    CrossRef

  10. 10
    Roberto Romeo, Salvatore V. Giofrè, Beatrice Macchi, Emanuela Balestrieri, Antonio Mastino, Pedro Merino, Caterina Carnovale, Giovanni Romeo, Ugo Chiacchio, Truncated Reverse Isoxazolidinyl Nucleosides: A New Class of Allosteric HIV-1 Reverse Transcriptase Inhibitors, ChemMedChem, 2012, 7, 4
  11. 11
    Mohsine Driowya, Alexandre Puissant, Guillaume Robert, Patrick Auberger, Rachid Benhida, Khalid Bougrin, Ultrasound-assisted one-pot synthesis of anti-CML nucleosides featuring 1,2,3-triazole nucleobase under iron-copper catalysis, Ultrasonics Sonochemistry, 2012, 19, 6, 1132

    CrossRef

  12. 12
    Erik De Clercq, A 40-Year Journey in Search of Selective Antiviral Chemotherapy*, Annual Review of Pharmacology and Toxicology, 2011, 51, 1, 1

    CrossRef

  13. 13
    Dana Hocková, Antonín Holý, Graciela Andrei, Robert Snoeck, Jan Balzarini, Acyclic nucleoside phosphonates with a branched 2-(2-phosphonoethoxy)ethyl chain: Efficient synthesis and antiviral activity, Bioorganic & Medicinal Chemistry, 2011, 19, 15, 4445

    CrossRef

  14. 14
    Erik De Clercq, Acyclic nucleoside phosphonates: An unfinished story, Collection of Czechoslovak Chemical Communications, 2011, 76, 7, 829

    CrossRef

  15. 15
    Stefano Alcaro, Claudia Alteri, Anna Artese, Francesca Ceccherini-Silberstein, Giosuè Costa, Francesco Ortuso, Ada Bertoli, Federica Forbici, Maria Mercedes Santoro, Lucia Parrotta, Philippe Flandre, Bernard Masquelier, Diane Descamps, Vincent Calvez, Anne-Genevieve Marcelin, Carlo Federico Perno, Tobias Sing, Valentina Svicher, Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine, ChemMedChem, 2011, 6, 12
  16. 16
    Stefano Alcaro, Claudia Alteri, Anna Artese, Francesca Ceccherini-Silberstein, Giosuè Costa, Francesco Ortuso, Lucia Parrotta, Carlo Federico Perno, Valentina Svicher, Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase, Drug Resistance Updates, 2011, 14, 3, 141

    CrossRef

  17. 17
    Judith M. Rollinger, Michaela Schmidtke, The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery, Medicinal Research Reviews, 2011, 31, 1
  18. 18
    Erik De Clercq, The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures, Medicinal Research Reviews, 2011, 31, 1
  19. 19
    Cátia Teixeira, José R.B. Gomes, Paula Gomes, François Maurel, Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug, European Journal of Medicinal Chemistry, 2011, 46, 4, 979

    CrossRef

  20. 20
    Tomohiro Ishikawa, Eiji Konishi, Combating Japanese encephalitis: Vero-cell derived inactivated vaccines and the situation in Japan, Future Virology, 2010, 5, 6, 785

    CrossRef

  21. 21
    Hengqiao Xiao, Yangen Huang, Feng-Ling Qing, Highly diastereoselective synthesis of α-trifluoromethylated α-propargylamines by acetylide addition to chiral CF3-substituted N-tert-butanesulfinyl ketimines, Tetrahedron: Asymmetry, 2010, 21, 24, 2949

    CrossRef

  22. 22
    Erik De Clercq, Historical Perspectives in the Development of Antiviral Agents Against Poxviruses, Viruses, 2010, 2, 6, 1322

    CrossRef

  23. 23
    Erik De Clercq, In search of a selective therapy of viral infections, Antiviral Research, 2010, 85, 1, 19

    CrossRef

  24. 24
    Leslie J. Marshall, Eugene O. Major, Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal Leukoencephalopathy, Journal of Neuroimmune Pharmacology, 2010, 5, 3, 404

    CrossRef

  25. 25
    Taťána Majerová, Hillary Hoffman, Filip Majer, Therapeutic targets for influenza – perspectives in drug development, Collection of Czechoslovak Chemical Communications, 2010, 75, 1, 81

    CrossRef

  26. 26
    Anna Lundin, Tomas Bergström, Loubna Bendrioua, Nina Kann, Beata Adamiak, Edward Trybala, Two novel fusion inhibitors of human respiratory syncytial virus, Antiviral Research, 2010, 88, 3, 317

    CrossRef

  27. 27
    Erik De Clercq, Yet another ten stories on antiviral drug discovery (part D): Paradigms, paradoxes, and paraductions, Medicinal Research Reviews, 2010, 30, 4
  28. 28
    Erik De Clercq, Antiviral chemotherapy in 2009:quo vadis?, Future Virology, 2009, 4, 4, 313

    CrossRef

  29. 29
    Erik De Clercq, ChemInform Abstract: Another Ten Stories in Antiviral Drug Discovery. Part C. “Old” and “New” Antivirals, Strategies, and Perspectives, ChemInform, 2009, 40, 37
  30. 30
    Erik De Clercq, The history of antiretrovirals: key discoveries over the past 25 years, Reviews in Medical Virology, 2009, 19, 5
  31. 31
    Erik De Clercq, Outlook of the Antiviral Drug Era, Now More Than 50 Years after Description of the First Antiviral Drug,